Multiple-Sclerosis-Information-Page

Multiple Sclerosis Information Page


What research is being done?

Scientists at the National Institute of Neurological Disorders and Stroke and elsewhere continue their extensive efforts to create new and better therapies for MS.  One of the most promising MS research areas involves naturally occurring antiviral proteins known as interferons. Beta interferon has been shown to reduce the number of exacerbations and may slow the progression of physical disability. When attacks do occur, they tend to be shorter and less severe.  In addition, there are a number of treatments under investigation that may curtail attacks or improve function.  Over a dozen clinical trials testing potential therapies are underway, and additional new treatments are being devised and tested in animal models.

In 2001, the National Academies/Institute of Medicine, a Federal technical and scientific advisory agency, prepared a strategic review of MS research. To read or download the National Academies Institute of Medicine report, go to: "Multiple Sclerosis: Current Status and Strategies for the Future."

Information from the National Library of Medicine’s MedlinePlus
Multiple Sclerosis

×
What research is being done?

Scientists at the National Institute of Neurological Disorders and Stroke and elsewhere continue their extensive efforts to create new and better therapies for MS.  One of the most promising MS research areas involves naturally occurring antiviral proteins known as interferons. Beta interferon has been shown to reduce the number of exacerbations and may slow the progression of physical disability. When attacks do occur, they tend to be shorter and less severe.  In addition, there are a number of treatments under investigation that may curtail attacks or improve function.  Over a dozen clinical trials testing potential therapies are underway, and additional new treatments are being devised and tested in animal models.

In 2001, the National Academies/Institute of Medicine, a Federal technical and scientific advisory agency, prepared a strategic review of MS research. To read or download the National Academies Institute of Medicine report, go to: "Multiple Sclerosis: Current Status and Strategies for the Future."

Information from the National Library of Medicine’s MedlinePlus
Multiple Sclerosis

Scientists at the National Institute of Neurological Disorders and Stroke and elsewhere continue their extensive efforts to create new and better therapies for MS.  One of the most promising MS research areas involves naturally occurring antiviral proteins known as interferons. Beta interferon has been shown to reduce the number of exacerbations and may slow the progression of physical disability. When attacks do occur, they tend to be shorter and less severe.  In addition, there are a number of treatments under investigation that may curtail attacks or improve function.  Over a dozen clinical trials testing potential therapies are underway, and additional new treatments are being devised and tested in animal models.

In 2001, the National Academies/Institute of Medicine, a Federal technical and scientific advisory agency, prepared a strategic review of MS research. To read or download the National Academies Institute of Medicine report, go to: "Multiple Sclerosis: Current Status and Strategies for the Future."

Information from the National Library of Medicine’s MedlinePlus
Multiple Sclerosis


Definition
Definition
Treatment
Treatment
Prognosis
Prognosis
Clinical Trials
Clinical Trials
Organizations
Organizations
Publications
Publications
460 Totten Pond Rd. Suite 420
Waltham, MA 02451
Tel: 781-487-0008
22100 Gratiot Avenue
Eastpointe, MI 48021-2227
Tel: 586-776-3900; 800-598-4668
Special Education & Rehabilitative Services Communications & Customer Service Team
550 12th Street, SW, Rm. 5133
Washington, DC 20202-2550
Tel: 202-245-7307; 202-205-5637 (TTD)
375 Kings Highway North
Cherry Hill, NJ 08034
Tel: 856-488-4500; 800-532-7667
6520 North Andrews Avenue
Ft. Lauderdale, FL 33309-2130
Tel: 954-776-6805; 888-MSFOCUS (673-6287)
18809 Cox Avenue
Suite 190
Saratoga, CA 95070
Tel: 408-871-2410
600 Highway 169 South
Suite 1725
Minneapolis, MN 55426
Tel: 763-553-0020
733 Third Avenue
3rd Floor
New York, NY 10017-3288
Tel: 800-FIGHT-MS (800-344-4867)
8400 Corporate Drive
Suite 500
Landover, MD 20785
Tel: 301-459-5900; 800-346-2742; 301-459-5984 (TTY)
801 18th Street, NW
Washington, DC 20006-3517
Tel: 202-USA-1300 (872-1300); 800-555-9140
63 West Main Street
Suite H
Freehold, NJ 07728
Tel: 800-838-0879; 732-577-8899